Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

36.64 +1.74 (+4.99%)

Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,518,813
Open	35.04
Bid (Size)	33.54 (100)
Ask (Size)	41.33 (100)
Prev. Close	34.90
Today's Range	35.02 - 37.00
52wk Range	22.24 - 46.00
Shares Outstanding	58,951,469
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

4 High-Risk Stocks Built for Big Returns ↗

October 14, 2026

These speculative investments could turbocharge a portfolio to market-beating returns.

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

August 11, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

52-Week Range 20.3% below 52-week high

36.64

22.2452W Low 46.0052W High

1 Week

29.671W Low 35.021W High

Agios Pharmaceuticals, Inc. - Common Stock (AGIO) traded between $22.24 and $46.00 over the past 52 weeks and last traded at $36.64, 20.3% below its 52-week high. Over the past week it ranged between $29.67 and $35.02.

Past 12 Months

+21.3%

+7.9%

-8.5%

+35.4%

+34.8%

-14.1%

1W +$6.43

1M +$2.69

3M -$3.42

6M +$9.57

YTD +$9.46

1Y -$6.01

AGIO was -14.1% over the past year, +35.4% over six months, +34.8% year to date, +21.3% in the last week.

12 Months vs Market

AGIO

-14.1%

DIA

+12.3%

SPY

+14.6%

QQQ

+17.3%

IWM

+11.1%

Over the past 12 months AGIO returned -14.1% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 1.35× 3-mo avg

Today 1,518,813 3-mo avg 1.1M

1.4M

1.2M

1.1M

YTD

1.1M

1.2M

AGIO most recently traded 1,518,813 shares against a 3-month average daily volume of 1.1M.

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

August 04, 2026

From Pomerantz LLP

Via GlobeNewswire

Agios Pharmaceuticals (NASDAQ:AGIO) Surges on Q2 Revenue Beat Driven by PYRUKYND Sales ↗

July 30, 2026

Via Chartmill

Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally ↗

April 29, 2026

Via Chartmill

Agios Pharmaceuticals Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

July 28, 2026

From Pomerantz LLP

Via GlobeNewswire

Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week ↗

July 10, 2026

Via The Motley Fool

Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) ↗

July 07, 2026

Via The Motley Fool

The market is filled with gapping stocks in Tuesday's session. ↗

July 07, 2026

Via Chartmill

Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss ↗

June 13, 2026

Via MarketBeat

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia

May 22, 2026

From Avanzanite Bioscience B.V. and Agios Pharmaceuticals, Inc.

Via Business Wire

Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances ↗

May 19, 2026

Via MarketBeat

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗

May 02, 2026

Via The Motley Fool

Agios (AGIO) Q1 2026 Earnings Call Transcript ↗

April 30, 2026

Via The Motley Fool

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday ↗

April 29, 2026

Via The Motley Fool

Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗

April 24, 2026

Via The Motley Fool

Agios (AGIO) Q3 2024 Earnings Call Transcript ↗

April 22, 2026

Via The Motley Fool

Agios (AGIO) Q2 2025 Earnings Call Transcript ↗

April 21, 2026

Via The Motley Fool

Agios (AGIO) Q3 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗

April 20, 2026

Via Chartmill

Here's Why Agios Pharmaceuticals Crashed 23% Today ↗

April 20, 2026

Via The Motley Fool

What's going on in today's session ↗

April 20, 2026

Via Chartmill

These stocks are gapping in today's session ↗

April 20, 2026

Via Chartmill

Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon? ↗

March 31, 2026

Via Benzinga

Frequently Asked Questions

Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?

Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market

What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?

The current price of Agios Pharmaceuticals, Inc. - Common Stock is 36.64

When was Agios Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 10/20/26 04:00 PM ET

What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 2.16B

How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?

Agios Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.